Arteriosclerosis, Thrombosis, Vascular Biology
SOLOIST WHF and SCORED Results
Investigator Deepak Bhatt, MD summarizes the results of 2 trials on dual SGT1 and SGT2 inhibition, which he presented during Scientific Sessions 2020.
The ATVB Council focuses on arteriosclerosis, thrombosis and vascular biology. The council advances research, addresses prevention, improves diagnosis and treatment, and works actively with other organizations. It shares reliable information through its annual conference, awards and lectures, and in the AHA’s journal, Arteriosclerosis, Thrombosis, and Vascular Biology.
PVD Council partners are focused on improving the care of patients with vascular diseases by advancing science, education, advocacy, and improved healthcare delivery. Partners support the AHA mission through active involvement in the council’s scientific initiatives and educational programs, including the annual Scientific Sessions and Vascular Discovery meetings.